supported by grants from National Natural Science Foundation of China(No.81500172 and No.81202962);Integrated Innovative Team for Major Human Diseases Program of Tongji Medical College,HUST;Clinical Research Physician Program of Tongji Medical College,HUST
Bortezomib,the first potent therapeutic proteasome inhibitor,has been suggested as a standard care in patients with newly diagnosed and relapsed multiple myeloma(MM).However,evidence bearing on the efficacy and safe...
Partially supported by the Natural Science Foundation of Hubei Province(No.2013CFB389);the National Natural Science Foundation of China(No.81202962)
Objective: To study the antitumor effects and associated mechanisms of extract of the Smilax china L. rhizome (SCR) on ovarian cancer cells. Methods: Ovarian cancer cells A2780 were treated with different concentr...